Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin: Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 650-661

  Minotti, Giorgio ^a   Mancuso, Cesare ^a   Frustaci, Andrea ^a   Mordente, Alvaro ^a   Santini, Stefano A ^a   Calafiore, Antonio Maria ^b   Liberi, Giovanni ^b   Gentiloni, Nicolo' ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

cardiotoxicity; doxorubicin; free radicals; iron; lipid peroxidation

Indexed keywords

DOXORUBICIN; ISOFERRITIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER; CANCER PATIENT; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029910238     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118836     Document Type: Article

References (81)

1. Minow, R.A., R.S. Benjamin, and J.A. Gottlieb. 1975. Adriamycin (NSC 123127) cardiomyopathy - an overview with determination of risk factors. Cancer Chemother. Rep. 6:198-201.
2. 2: evidence for enhanced toxicity with multiagent chemotherapy. Am. J. Hematol. 36:217-218.
3. Powis, G. 1989. Free radical formation by antitumor quinones. Free Radic. Biol. & Med. 6:63-101.
4. Olson, R.D., and P.S. Mushlin. 1990. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4:3076-3086.
5. Doroshow, J.H. 1991. Doxorubicin-induced cardiotoxicity. N. Engl. J. Mol. 324:843-845.
6. Borrello, S., E. De Leo, H. Wohlrab, and T. Galeotti. 1992. Manganese deficiency and transcriptional regulation of mitochondrial superoxide dismutase. FEBS Lett. 3:249-254.
7. Mordente, A., S.A. Santini, G.A.D. Miggiano, G.E. Martorana, T. Petitti, G. Minotti, and B. Giardina. 1994. The interaction of short-chain coenzyme O analogs with different redox state of myoglobin. J. Biol. Chem. 269:27394-27400.
8. Minotti, G. 1993. Sources and role of iron in lipid peroxidation. Chem. Res. Toxicol. 6:134-146.
9. Theil, E.C. 1983. Ferritin: structure, function, and regulation. In Iron Binding Proteins Without Cofactors or Sulfur Clusters. B.C. Theil, G.L. Eichorn, and L. Marzili, editors. Elsevier Science Publishing. Co., Inc., New York. 1-38.
10. Ryan, T.P., and S.D. Aust. 1992. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 22:119-141.
11. Rajagopalan, S., P.M. Politi, B.K. Sinha, and C.E. Myers. 1988. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48:4766-4769.
12. Tesoriere, L., M. Ciaccio, M. Valenza, A. Bongiorno, E. Maresi, R. Albiero, and M.A. Livrea. 1994. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. J. Pharmacol. Exp. Ther. 269:430-436.
13. Siveski-Iliskovic, N., M. Hill, D.A. Chow, and P.K. Singal. 1995. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation. 91:10-15.
14. Sridhar, R., C. Dwivedi, J. Anderson, P.B. Baker, H.M. Sharma, P. Desai, F.N. Engineer. 1992. Effects of verapamil on the acute toxicity of doxorubicin in vivo. J. Natl. Cancer Inst. 84:1653-1659.
15. Fischer, J.C., R.L. Tackett, E.W. Howerth, and M.A. Johnson. 1992. Copper and selenium deficiencies do not enhance the cardiotoxicity in rats due to chronic doxorubicin treatment. J. Nutr. 122:2128-2137.
16. Baird, M.B., J.L. Hough, and G.T. Sfeir. 1993. Accumulation of malondialdehyde in mouse heart following acute dosing with adriamycin is strain specific and unaffected by cardiac catalase status. Res. Commun. Chem. Pathol. Pharmacol. 80:363-366.
17. Pract, M., and J.M. Ruysschaert. 1993. In vivo and in vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives. Biochim. Biophys. Acta. 1149:79-85.
18. Mor, V., L. Laliberte, J.N. Morris, and M. Wiemann. 1984. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer. 53:2002-2007.
19. Ledwozyw, A., J. Michalak, A. Stepien, and A. Kadziolka. 1986. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta. 155:275-284.
20. Brown, K.M., P.C. Morrice, and G. Duthie. 1994. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am. J. Clin. Nutr. 60:383-387.
21. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 332:1198-1203.
22. Seldinger, S. 1953. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 39:368-376.
23. Folch, J.M., M. Lees, and H.S. Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
24. Ambrosio, G., J.T. Flaherty, C. Duilio, I. Tritto, G. Santoro, P.P. Elia, M. Condorelli, and M. Chiariello. 1991. Oxygen radical generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J. Clin. Invest. 87: 2056-2066.
25. Corongiu, F.P., S. Banni, and M. A. Dessi'. 1989. Conjugated dienes detected in tissue lipid extracts by second-derivative spectrophotometry. Free Radical Biol. & Med. 7:183-186.
26. Situnayake, R.D., B.J. Crump, A.V. Zezulka, M. Davis, B. McConkey, and D.I. Thurnham. 1990. Measurement of conjugated diene lipids by derivative spectroscopy in heptane extracts of plasma. Ann. Clin. Biochem. 27:258-266.
27. Jiang, Z.Y., J.V. Hunt, and S.P. Wolff. 1992. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low density lipoprotein. Anal. Biochem. 26:853-856.
28. Nourooz-Zadeh, J., J. Tajaddini-Sarmadi, and S.P. Wolff. 1994. Measurement of plasma hydroperoxide concentrations by the ferrous-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220:403-409.
29. Nakamura, T., and H. Maeda. 1991. A simple assay for lipid hydroperoxides based on triphenylphosphine oxidation and high performance liquid Chromatography. Lipids. 26:765-768.
30. Levi, S., S.J. Yewdall, P.M. Harrison, P. Santambrogio, A. Cozzi, E. Rovida, A. Albertini, and P. Arosio. 1992. Evidence that H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem. J. 288:591-596.
31. Miller, D.M., G.R. Buettner, and S.D. Aust. 1990. Transition metals as catalysts of "autoxidation" reactions. Free Radic. Biol. & Med. 8:95-108.
32. Minotti, G., and S.D. Aust. 1992. Redox cycling of iron and lipid peroxidation. Lipids. 27:219-226.
33. Minotti, G., and S.D. Aust. 1987. The requirement for Fe(III) in the initiation of lipid peroxidalion by Fe(II) and hydrogen peroxide. J. Biol. Chem. 262:1098-1104.
34. Crichton, R.R., and R.J. Ward. 1992. Iron metabolism: new perspectives in view. Biochemistry. 31:11255-11264.
35. Buege, J.A., and S.D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310.
36. Ryan, T.P., V.M. Samokyszyn, S. Dellis, and S.D. Aust. 1990. Effects of (+)-1.2-bis(3,5-dioxopiperazin-1-yl)propane (ADR-529) on iron-catalyzed lipid peroxidation. Chem. Res. Toxicol. 3:384-390.
37. Cecchini, R., O.I. Aruoma, and B. Halliwell. 1990. The action of hydrogen peroxide on the formation of thiobarbituric acid reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test. Fee Rad. Res. Commun. 10:245-258.
38. Boren, J., L. Graham, M. Weitesten, J. Scott, A. White, and S.-O. Olofsson. 1992. The assembly and secretion of apoB 100-containing lipoproteins in Hep G2 cells. J. Biol. Chem. 267:9858-9867.
39. Kontron Instruments Analytical Division. 1992. Rapid separation of serum lipoproteins by single-spin vertical discontinuous density gradient ultracentrifugation. Application Note No. 5-92.
40. Frei, B., and J.M. Graziano. 1993. Content of amioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibilty of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34: 2135-2145.
41. Minotti, G., A.F. Cavaliere, A. Mordente, M. Rossi, R. Schiavello, R. Zamparelli, and G.F. Possati. 1995. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. J. Clin. Invest. 95:1595-1605.
42. Ulvik, R., and I. Romslo. 1979. Studies on the mobilization of iron from ferritin by isolated rat liver mitochondria. Biochim. Biophys. Acta. 588:256-271.
43. Stoscheck, C.M. 1990. Quantitation of Protein. Methods Enzymol. 182: 50-68.
44. Luzzago, A., P. Arosio, C. Iacobello, G. Ruggeri, L. Capucci, E. Brocchi, F. De Simone, D. Gamba, E. Gabri, S. Levi, et al. 1986. Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim. Biophys. Acta. 872:61-71.
45. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
46. Smith, G.N., M. Taj, and J.M. Braganza. 1991. On the identification of a conjugated diene component of duodenal bile as 9Z.11E-octodecadienoic acid. Free Radical Biol. & Med. 10:13-21.
47. Corongiu, F.P., G. Poli, M.U. Dianzani, K.H. Cheeseman, and T.F. Slater. 1986. Lipid peroxidation and molecular damage to polyunsaturated fatty acids in rat liver. Recognition of two classes of hydroperoxides formed under conditions in vivo. Chem. Biol. Interact. 59:147-155.
48. Reiter, R., and R.F. Burk. 1987. Effect of oxygen tension on the generation of alkanes and malondialdehyde by peroxidizing rat liver microsomes. Biochem. Pharmacol. 36:925-929.
49. Slater, T.F. 1984. An overview of methods used for detecting lipid peroxidation. Methods Enzymol. 105:283-293.
50. Levi, S., P. Santambrogio, A. Cozzi, E. Rovida, B. Corsi, E. Tamborini, S. Spada, A. Albertini, and P. Arosio. 1994. The role of L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J. Mol. Biol. 238:649-654.
51. 2 dependent release of fatty acids from peroxidized membranes. J. Free Radicals Biol. & Med. 1:263-271.
52. 2 isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:10721-10725.
53. Girotti, M.J., N. Khan, and B.A. McLellan. 1991. Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. J. Trauma. 31:32-35.
54. Keen, R.R., L. Stella, D.P. Flanigan, and W.E. Lands. 1991. Differential detection of plasma lipid hydroperoxides in sepsis. Crit. Care Med. 19:1114-1119
55. Clot, P., M. Tabone, S. Arico, and E. Albano. 1994. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut. 35:1637-1643.
56. Carbonneau, M.A., E. Peuchant, D. Sess, P. Canioni, and M. Clerc. 1991. Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin. Chem. 37:1423-1429.
57. Muindi, J.F., H.I. Scher, J.R. Rigas, R.P. Warrell, and C.W. Young. 1994. Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans retinoic acid in patients with advanced cancer. Cancer Res. 54:2125-2128.
58. Donagh, J., E.T. Fossel, R.L. Kradin, S.M. Dubinett, M. Laposata, and Y.A. Hallaq. 1992. Effects of tumor necrosis factor-α on peroxidation of plasma lipoprotein lipids in experimental animals and patients. Blood. 80:3217-3226.
59. Tchekmedyan, N.S., D. Zahyna, C. Halpert, and D. Heber. 1992. Clinical aspects of nutrition in advanced cancer. Oncology (Basel). 49(Suppl. 2):3-7.
60. Malvy, D.J., B. Burtschy, J. Arnaud, D. Sommelet, G. Leverger, L. Dostalova, J. Drucker, and O. Amedee-Manesme. 1993. Serum beta-carotene and antioxidant micronutrients in children with cancer. The "Cancer children and antioxidant micronutrients" French Study Group. Int. J. Epidemiol. 22: 761-771.
61. Stahelin, B. 1993. Critical re-appraisal of vitamins and trace minerals in nutritional support of cancer patients. Support. Care Cancer. 1:295-297.
62. Chautan, M., J. Leonardi, R. Calaf, P. Lechene, R. Grataroli, H. Portugal, A.M. Pauli, H. Lafont, and G. Nalbone. 1992. Heart and liver membrane phospholipid homeostasis during acute administration of various antitumoral drugs to the rat. Biochem. Pharmacol. 44:1139-1147.
63. 2 by adriamycin in vitro. Role of drug-lipid interactions. J. Biol. Chem. 266:6302-6307.
64. Minotti, G., and S.D. Aust. 1987. An investigation into the mechanism of citrate-Fe(II) dependent lipid peroxidation. Free Radical Biol. & Med. 3:379-387.
65. Braughler, J.M., L.A. Duncan, and R.L. Chase. 1986. The involvement of iron in lipid peroxidation: importance of ferric to ferrous ratios in initiation. J. Biol. Chem. 261:10282-10289.
66. Goddard, J.G., and G.D. Sweeney. 1987. Delayed ferrous iron-dependent peroxidation of rat liver microsomes. Arch. Biochem. Biophys. 259:372-381.
67. Ursini, F., M. Maiorino, P. Hochstein, and L. Ernster. 1989. Microsomal lipid peroxidation: mechanisms of initiation. Free Radical Biol. & Med. 6:31-36.
68. Ko, K.M., and D.V. Godin. 1990. Ferric iron dependent lipid peroxidation in erythrocyte membranes: effects of phytic acid and butylated hydroxytoluene. Mol. Cell. Biochem. 95:125-131.
69. Kukielka, E., and A.I. Cederbaum. 1990. NADPH- and NADH- dependent oxygen radical generation by rat liver nuclei in the presence of redox cycling agents and iron. Arch. Biochem. Biophys. 283:326-333.
70. 2+ pump ATPase of human red blood cell membrane. Biochem. Pharmacol. 46: 525-534.
71. Minotti, G. 1990. NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation. Arch. Biochem. Biophys. 277:268-276.
72. Wissel, P.S., R.A. Galbraith, S. Sassa, and A. Kappas. 1988. Tin-protoporphyrin inhibits heme oxygenase and prevents the decline in hepatic heme and cytochrome P-450 contents produced in nude mice by tumor transplantation. Biochem. Biophy. J. Res. Commun. 150:822-827.
73. Seiser, C., S. Teixeira, and L.C. Kuhn. 1993. Interleukin-2-dependent transcriplional and post-transeriptional regulation of transferrin receptor mRNA. J. Biol. Chem. 268:13074-13080.
74. r 66,000 Microsomal Iron Protein that stimulates NADPH oxidation. J. Biol. Chem. 267:7611-7614.
75. Rothman, R.A., J.A. Serroni, and J.L. Farber. 1992. Cellular pool of transient ferric iron, chelatable by desferrioxamine and distinct from ferritin, that is involved in oxidative injury. Mol. Pharmacol. 42:703-710.
76. deSilva, D., and S.D. Aust. 1992. Stoichiometry of Fe(II) oxidation during ceruloplasmin-catalyzed loading of ferrilin. Arch. Biochem. Biophys. 298: 259-264.
77. Minotti, G. 1989. Adriamycin-dependent release of iron from microsomal membranes. Arch. Biochem. Biophys. 268:398-403.
78. Weitzman, S.A., B. Lorell, R.W. Carey, S. Kaufman, and T.P. Stossel. 1980. Prospective studies of tocopherol prophylaxis for anthracycline cardiac toxicity. Am. J. Cardiol. 56:157-161.
79. Myers. C., R. Bonow, S. Palmieri, J. Jenkins, B. Corden, G. Locker, J. Doroshow, and S.A. Epstein. 1983. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetyleysteine. Sem. Oncol. 10(Suppl.):53-55.
80. Muggia, F.M. 1994. Cytoprotection: concepts and challenges. Support. Care Cancer. 2:377-379.
81. Malisza, K.L., and B.B. Hasinoff. 1995. Doxorubicin reduces the iron (III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals. Arch. Biochem. Biophys. 316:6811-688.